ObsEva (NASDAQ:OBSV) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the stock.

ObsEva Stock Performance

ObsEva has a 1-year low of $0.08 and a 1-year high of $2.14. The stock has a market capitalization of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68. The firm’s 50 day simple moving average is $0.01.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.